TriangleNCT01026220 · OUTCOME
Second-event-free Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- NUMBER
- Unit
- Probability of survival
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- At 4 years from enrollment
What was measured
Second event here is defined as any relapse/progression of Hodgkin Lymphoma (HL) or a previously reported second malignant neoplasm (SMN), a new SMN, or death after a first event which can be relapse/progression of HL, SMN, biopsy-proven HL following completion of Consolidation for Slow Early Response (SER) patient, positive bilateral bone marrow biopsy following completion of Consolidation for Stage IV patient, or death. If death occurs as the 1st event, it also counts as the 2nd event.
Analysis population: This analysis excludes n=20 patients who had protocol early terminations or deviations (n=4 Regimen I, n=12 Regimen II, and n=4 Induction only).
Groups in this outcome
Group 2
Regimen 1
Group 3
Regimen II
| Group | Source count |
|---|---|
| Group 2 | 77 |
| Group 3 | 68 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Group 2 | 0.94 | Not reported | 0.84 | 0.98 | Not reported |
| Group 3 | 0.88 | Not reported | 0.77 | 0.94 | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- lower Limit
- 0.84
- upper Limit
- 0.98
- value
- 0.94
- group Id
- OG001
- lower Limit
- 0.77
- upper Limit
- 0.94
- value
- 0.88
- denoms
- counts
- group Id
- OG000
- value
- 77
- group Id
- OG001
- value
- 68
- units
- Participants
- description
- Second event here is defined as any relapse/progression of Hodgkin Lymphoma (HL) or a previously reported second malignant neoplasm (SMN), a new SMN, or death after a first event which can be relapse/progression of HL, SMN, biopsy-proven HL following completion of Consolidation for Slow Early Response (SER) patient, positive bilateral bone marrow biopsy following completion of Consolidation for Stage IV patient, or death. If death occurs as the 1st event, it also counts as the 2nd event.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Regimen 1
- id
- OG000
- title
- Group 2
- description
- Regimen II
- id
- OG001
- title
- Group 3
- param Type
- NUMBER
- population Description
- This analysis excludes n=20 patients who had protocol early terminations or deviations (n=4 Regimen I, n=12 Regimen II, and n=4 Induction only).
- reporting Status
- POSTED
- time Frame
- At 4 years from enrollment
- title
- Second-event-free Survival
- type
- SECONDARY
- unit Of Measure
- Probability of survival
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice